NEW YORK (GenomeWeb News) - Enzo Biochem today said that a federal court issued a ruling supporting the company's claims that "hundreds" of products marketed by certain companies infringe eight of Enzo's patents.
 
The ruling allows Enzo to pursue patent-infringement claims against Affymetrix, Roche, Amersham, PerkinElmer, Sigma Aldrich, Orchid Biosciences and Molecular Probes. It also enables Enzo to claim that the defendants breached their contractual obligations to Enzo.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.